- Home
- KYNB vs SST Comparison
KYNB vs SST Comparison
Compare KYNB & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYNB | SST |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 34.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KYNB | SST |
|---|---|---|
| Price | $7.43 | $3.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 28.9K | 7.0K |
| Earning Date | 03-16-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 53.38 | N/A |
| Revenue | $8,298,000.00 | ★ $289,784,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.15 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.85 | $2.90 |
| 52 Week High | $21.94 | $15.00 |
Technical Indicators
Market Signals| Indicator | KYNB | SST |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 33.91 |
| Support Level | $7.50 | $3.45 |
| Resistance Level | $8.25 | $4.25 |
| Average True Range (ATR) | 0.66 | 0.22 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 10.47 | 17.13 |
Price Performance
Historical ComparisonAbout KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.